Skip to main content
Daily Report

Daily Cosmetic Research Analysis

10/15/2025
3 papers selected
3 analyzed

A registered randomized controlled trial shows toluidine blue-based photodynamic therapy can match chlorhexidine and fluoride varnish in reducing plaque and preventing white spot lesions during fixed orthodontic treatment. A systematic review maps current AI tools across oral and maxillofacial cosmetic surgery, highlighting promising accuracy but pervasive bias and limited validation. A long-term single-center case series demonstrates that customized, CAD/CAM titanium implants enable precise res

Summary

A registered randomized controlled trial shows toluidine blue-based photodynamic therapy can match chlorhexidine and fluoride varnish in reducing plaque and preventing white spot lesions during fixed orthodontic treatment. A systematic review maps current AI tools across oral and maxillofacial cosmetic surgery, highlighting promising accuracy but pervasive bias and limited validation. A long-term single-center case series demonstrates that customized, CAD/CAM titanium implants enable precise resection and excellent cosmetic reconstruction for cranial fibrous dysplasia.

Research Themes

  • Noninvasive biofilm control and lesion prevention in orthodontics using photodynamic therapy
  • Artificial intelligence for diagnosis, planning, and outcome assessment in cosmetic surgery
  • Personalized, CAD/CAM-based craniofacial reconstruction with custom titanium implants

Selected Articles

1. The influence of photodynamic therapy on the supragingival plaque accumulation and bacterial composition in orthodontic patients: a randomized controlled trial.

78Level IRCT
European journal of orthodontics · 2025PMID: 41091662

In a registered, single-blind, four-arm RCT (n=48; 40 analyzed), toluidine blue-based 660 nm photodynamic therapy reduced plaque indices comparably to chlorhexidine and fluoride varnish and lowered total supragingival bacterial counts. No new white spot lesions occurred in PDT or CHX groups, and no harms were reported over 18 weeks.

Impact: Provides randomized evidence that PDT can substitute or complement chemical antiseptics for biofilm control during orthodontic treatment, with added benefit of WSL prevention and no reported harms.

Clinical Implications: Clinicians may consider protocolized PDT (toluidine blue plus 660 nm laser at bonding and 6–12 week intervals) to reduce plaque and gingival inflammation and help prevent white spot lesions without chlorhexidine-associated staining or taste disturbance.

Key Findings

  • PDT and chlorhexidine groups had significantly lower plaque indices than control at 12 and 18 weeks.
  • Total supragingival bacterial counts decreased significantly in PDT, chlorhexidine, and TCP-5% NaF groups over time.
  • No new white spot lesions were observed in PDT or chlorhexidine groups; no harms were reported.

Methodological Strengths

  • Prospective, randomized, four-arm, single-blind design with trial registration
  • Objective, multi-timepoint outcomes including plaque index, quantitative bacterial counts, gingival index, and WSL assessment

Limitations

  • Single-center study with modest sample size (40 analyzed)
  • Short follow-up (18 weeks) and no significant effect on subgingival bacterial composition

Future Directions: Conduct multicenter, double-blind RCTs with longer follow-up to assess caries incidence, optimize PDT parameters and intervals, evaluate patient-reported outcomes, and perform cost-effectiveness analyses.

BACKGROUND: Photodynamic therapy is an alternative to chlorhexidine and fluoride products in controlling oral health during fixed orthodontic treatment. OBJECTIVES: The primary aim was to evaluate the influence of toluidine blue-based dye and 660 nm diode laser on the accumulation of supragingival plaque and its bacterial composition in subjects undergoing fixed orthodontic treatment. The secondary outcomes were bacterial composition of the subgingival plaque, the gingival index, and evaluation of white spot lesions (WSL). TRIAL DESIGN: Four-arm parallel randomized controlled trial. METHODS: In this single-blind study, 48 orthodontic patients were randomly allocated to four groups: photodynamic therapy (PDT), 1% chlorhexidine (CHX) varnish, tricalcium phosphate (TCP) varnish containing 5% NaF, and negative control. The interventions were performed immediately after bonding (T0), 6 weeks (T1), and 12 weeks (T2) later. Plaque index, total bacteria count in the supragingival plaque, and the gingival index were determined at T0 (before bonding), T1, T2, and T3 (18 weeks). Quantitative PCR of the bacteria in the subgingival plaque and evaluation of the WSL on intraoral photographs were performed at T0 (before bonding) and T3. RESULTS: Forty participants were included in the analysis. At T2 and T3, in the PDT and CHX groups, a significantly lower plaque index was noted compared with the control group (T2: P = 0.002, P < 0.001; T3: P = 0.005, P < 0.001). The total bacteria count significantly decreased in the PDT, CHX, and TCP-5% NaF groups during the study period (P = 0.023, P < 0.001). PDT, CHX, and TCP-5% NaF did not significantly decrease the number of bacteria in the subgingival plaque compared with that in the control group. A significant decrease in gingival scores between T1 and T2 was noted in the PDT group (P = 0.016). No new WSLs were noticed in the PDT or CHX groups. The least number of advanced lesions was diagnosed in the PDT group. No harms were encountered. CONCLUSION: The effects of PDT on oral health were mostly comparable to those produced by CHX and TCP-5% NaF varnish and significantly different from those observed in the control group. TRIAL REGISTRATION: ClinicalTrials.gov NCT06331442.

2. Applications of Artificial Intelligence in Oral and Maxillofacial Cosmetic Surgery: A Systematic Review of Diagnostic, Planning, and Outcome Assessment Tools.

62.5Level ISystematic Review
Cureus · 2025PMID: 41089122

Across 14 included studies, AI tools achieved high accuracy for tasks including extraction difficulty prediction, orthognathic diagnostics, soft-tissue change prediction, and perioperative blood loss forecasting, often outperforming conventional models. However, most studies were retrospective and single-center with small, homogeneous datasets, yielding high risk of bias and limited external validity.

Impact: Provides the first consolidated evidence map of AI applications specific to oral and maxillofacial cosmetic surgery, clarifying performance ranges and key methodological gaps to guide clinical translation.

Clinical Implications: AI decision support may augment diagnosis and planning, but clinicians should demand prospective, multicenter validation and transparent reporting before integrating models into routine care.

Key Findings

  • Convolutional neural networks predicted third molar extraction difficulty with 78.9–90.2% accuracy; postoperative swelling prediction reached 98% accuracy.
  • Orthognathic diagnostic models using cephalograms and facial photos exceeded 90% accuracy with specificity up to 99%.
  • AI predicted soft-tissue changes with sub-millimeter errors and perioperative blood loss with mean errors <10 mL, but most studies were retrospective with high risk of bias.

Methodological Strengths

  • Comprehensive multi-database search with explicit inclusion criteria
  • Risk of bias appraisal using PROBAST-AI and detailed reporting of model performance

Limitations

  • Predominantly retrospective, single-center studies with small or homogeneous datasets
  • Heterogeneous tasks, inputs, and metrics precluded quantitative meta-analysis

Future Directions: Prioritize prospective multicenter validations, standardized reporting (TRIPOD-AI/CONSORT-AI), external test sets, and fairness auditing; integrate multimodal data and ensure model interpretability for safe deployment.

Artificial intelligence (AI) has rapidly expanded into oral and maxillofacial cosmetic surgery, offering potential improvements in diagnosis, surgical planning, perioperative risk assessment, and outcome prediction. Despite promising results, the extent of its clinical utility and methodological rigor across published studies remains unclear. This systematic review synthesized and critically appraised the applications of AI in oral and maxillofacial cosmetic surgery, focusing on diagnostic support, preoperative planning, and esthetic or functional outcome evaluation. A comprehensive search of PubMed, Cochrane, Scopus, and Web of Science from inception to November 2024 identified 11,031 records, of which 14 studies were included after screening. Data extraction captured study characteristics, AI techniques, input modalities, comparators, and outcomes, and the study quality was appraised using the PROBAST-AI tool. The included studies encompassed diverse AI applications. In third molar surgery, convolutional neural networks achieved 78.9-90.2% accuracy for extraction difficulty, while neural networks predicted postoperative swelling with 98% accuracy. In orthognathic diagnostics, models using cephalograms and facial photographs reported accuracies above 90%, with specificity up to 99%. For surgical planning, AI predicted soft-tissue changes with sub-millimeter error margins, outperforming conventional models. Perioperative risk models predicted blood loss with mean errors <10 mL, while aesthetic applications quantified age reduction post-rhinoplasty and generated simulations with high surgeon agreement. Despite these advances, most studies were retrospective, single-center, and limited by small or homogeneous datasets, with an overall high risk of bias. Overall, AI demonstrates strong potential for enhancing diagnostic accuracy, surgical planning, risk prediction, and esthetic evaluation in oral and maxillofacial cosmetic surgery. However, current evidence is constrained by methodological weaknesses, limited validation, and ethical concerns, including dataset bias and subjective outcome measures. Future research should prioritize prospective multicenter validation, standardized reporting frameworks, multimodal data integration, and transparent model design to enable safe and effective clinical translation.

3. Customized Titanium Implants for Cranial Fibrous Dysplasia: A Personalized Surgical Approach and Single-Center Experience.

54Level IVCase series
Operative neurosurgery (Hagerstown, Md.) · 2025PMID: 41090924

Over 12 years, 33 patients with cranial fibrous dysplasia underwent resection guided by computer-assisted templates and reconstruction with patient-specific 3D-printed titanium implants, achieving complete tumor removal, satisfactory cosmetic outcomes, and no reported complications, with a mean follow-up of 108 months.

Impact: Demonstrates the feasibility and long-term safety of CAD/CAM, patient-specific titanium cranioplasty for CFD, supporting personalized reconstruction with excellent cosmetic outcomes.

Clinical Implications: For craniofacial deformities due to fibrous dysplasia, surgeons can consider patient-specific titanium implants with computer-assisted planning to improve resection precision and cosmetic symmetry while minimizing complications.

Key Findings

  • Computer-assisted templates enabled precise tumor margin determination and resection planning.
  • Patient-specific, 3D-printed titanium implants achieved satisfactory cosmetic reconstruction with no reported intraoperative or postoperative complications.
  • Mean follow-up of 108 months confirmed durable outcomes after complete tumor removal.

Methodological Strengths

  • Standardized computer-assisted preoperative planning with patient-specific templates
  • Long-term follow-up with postoperative CT verification of outcomes

Limitations

  • Single-center case series without a control/comparator group
  • Potential selection and reporting bias; generalizability may be limited

Future Directions: Prospective multicenter cohorts comparing implant materials and planning workflows, patient-reported outcomes, and cost-effectiveness analyses are needed.

BACKGROUND AND OBJECTIVES: The optimal treatment for cranial fibrous dysplasia (CFD) is surgical resection and reconstruction, enhanced by computer-assisted techniques and custom-made implants. This study describes the surgical treatment of CFD using preoperative computer-assisted planning, a custom-made template, and titanium implants for reconstruction. METHODS: Over a 12-year period, 33 patients (19 males, 14 females) with monostotic CFD underwent surgical treatment involving tumor resection and reconstruction with custom titanium implants. The mean age was 38 years (range: 19-63). Preoperative computed tomography (CT) with 0.5-mm slices was used for precise planning. A computer-assisted template was created to determine tumor margins and minimize complications. Based on this, patient-specific titanium implants were designed and manufactured. During surgery, the template guided tumor removal and the implants were secured with miniscrews. Postoperative CT scans were performed for follow-up. RESULTS: Histopathological examination confirmed the diagnosis in all cases. The bone defect that occurred after resection during surgery was reconstructed using a patient-specific, 3-dimensional-printed titanium cranioplasty implant. No complications occurred during or after the surgery. Complete tumor removal and satisfactory cosmetic results were verified on postoperative CT scans. The mean follow-up duration was 108 months (range: 7-149 months). CONCLUSION: Computer-aided design and manufacturing of customized titanium implants provide a safe and effective approach for CFD reconstruction. This method allows precise resection, excellent cosmetic outcomes, and low complication rates, making it a reliable technique for cranioplasty.